問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

羅浩倫
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

38Cases

2025-08-01 - 2032-12-31

Phase III

Active
A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer
  • Condition/Disease

    Prostate Cancer

  • Test Drug

    Injectable

Participate Sites
5Sites

Recruiting5Sites

2023-12-01 - 2029-04-30

Phase III

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
9Sites

Recruiting9Sites

2024-10-01 - 2035-12-31

Phase II

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
3Sites

Not yet recruiting1Sites

Recruiting2Sites

2017-06-01 - 2021-01-06

Phase II

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
8Sites

Terminated7Sites

馮思中
Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

2017-09-26 - 2022-12-31

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
5Sites

Terminated5Sites

蘇柏榮
Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

顏厥全
Taipei Veterans General Hospital

Division of Hematology & Oncology

2018-06-15 - 2021-06-30

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Recruiting6Sites

林永昌
Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

2019-05-19 - 2027-01-25

Phase III

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
4Sites

Recruiting4Sites

2020-03-01 - 2032-06-30

Phase III

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Not yet recruiting4Sites

Recruiting3Sites

2020-10-26 - 2028-06-30

Phase III

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
8Sites

Not yet recruiting3Sites

Recruiting5Sites

2021-11-01 - 2022-08-29

Phase III

-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Recruiting6Sites

1 2 3 4